Kenta Iguchi
Overview
Explore the profile of Kenta Iguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ono Y, Numata K, Iguchi K, Uchiyama M, Asari M, Rino Y, et al.
Cancer Diagn Progn
. 2025 Mar;
5(2):216-222.
PMID: 40034953
Background/aim: Patients with unresectable advanced and recurrent colorectal cancer (CRC) and the mutation have poor prognosis, and conventional chemotherapy is often ineffective. This study aimed to retrospectively evaluate the clinicopathological...
2.
Iguchi K, Numata M, Sugiyama A, Saito K, Atsumi Y, Kazama K, et al.
Langenbecks Arch Surg
. 2024 Jun;
409(1):189.
PMID: 38896303
Purpose: Although there have been many reports on learning curves for robotic surgery, it is unclear how surgeons' conventional laparoscopic surgical skills influence their ability in performing robotic surgery for...
3.
Iguchi K, Shiozawa M, Uchiyama M, Asari M, Numata K, Rino Y, et al.
J Cancer Res Clin Oncol
. 2024 May;
150(5):281.
PMID: 38805050
Purpose: In metastatic colorectal cancer (mCRC), RAS mutation loss may occur during the standard-of-care regimen. In this study, we aimed to investigate the temporal dynamics of the RAS gene and...
4.
Kataoka K, Ouchi A, Suwa Y, Hirano H, Yamaguchi T, Takamizawa Y, et al.
Eur J Surg Oncol
. 2024 Apr;
50(6):108354.
PMID: 38657376
Although phase III randomized controlled trials (RCTs) represent the most robust statistical approach for answering clinical questions, they require massive expenditures in terms of time, labor, and funding. Ancillary and...
5.
Iguchi K, Sugiyama A, Mushiake H, Hasegawa S, Rino Y, Saito A, et al.
Asian J Endosc Surg
. 2024 Apr;
17(3):e13312.
PMID: 38626926
Background: In patients with stage II colon cancer (CC) undergoing minimally invasive surgery, the association between the clinical significance of lymph node yield and tumor localization remains unknown. We aimed...
6.
Iguchi K, Numata M, Atsumi Y, Sato T, Rino Y, Saito A
Colorectal Dis
. 2024 Apr;
26(5):1047-1052.
PMID: 38566354
Aim: Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC) is rapidly spreading. The robotic surgical techniques to approach lateral invasion, such as that of the pelvic plexus, have...
7.
Numata K, Shiozawa M, Ono Y, Iguchi K, Uchiyama M, Asari M, et al.
Oncology
. 2024 Feb;
102(10):841-849.
PMID: 38382488
Introduction: Anti-p53 antibody (p53Ab) is useful for monitoring colorectal cancer (CRC) recurrence. We retrospectively analyzed the clinical impact of p53Ab ratio (p53R) before and after surgery to predict recurrence in...
8.
Numata K, Numata M, Shirai J, Sawazaki S, Okamoto H, Godai T, et al.
J Surg Oncol
. 2023 Sep;
128(8):1372-1379.
PMID: 37753717
Aim: There are well-known methods for decompressing the colorectal tract before surgery, including transanal decompression tubes (TDT) and self-expanding metallic stents (SEMS). This study aimed to compare the short and...
9.
Iguchi K, Sugano N, Sugiyama A, Saito K, Atsumi Y, Kazama K, et al.
Colorectal Dis
. 2023 Jul;
25(8):1713-1717.
PMID: 37401036
Aim: During surgery for mid-transverse colon cancer (MTC), surgeons often face the dilemma of whether to mobilize the hepatic or splenic flexure. There is no established optimal minimally invasive surgical...
10.
Iguchi K, Numata M, Shiozawa M, Kazama K, Sawazaki S, Katayama Y, et al.
Langenbecks Arch Surg
. 2023 Jun;
408(1):222.
PMID: 37266706
Purpose: This study compared the surgical outcomes between laparoscopic colectomy (LC) and open colectomy (OC) for mid-transverse colon cancer (MTC). Methods: This multicenter retrospective study compared the short- and long-term...